KISQALI
Novartis Ag
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79156360 |
| Registration Number | 4820261 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Novartis Pharmaceuticals Corporation |
| Attorney Name | Maury M. Tepper, III |
| Law Office Assigned | M10 |
| Employee Name | PERKINS, ELLEN J |
Timeline
| 2014-10-02 | Application Filed |
| 2015-07-14 | Published for Opposition |
| 2015-09-29 | Location: PUBLICATION AND ISSUE SECTION |
| 2015-09-29 | Status: Live/Registered |
| 2015-09-29 | Trademark Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  NOVARTIS AG |
| Entity Statement | Aktiengesellschaft (AG) |
| Address | CH-4002 Basel CH |
| Legal Entity Type | |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system, pharmaceutical preparations for the prevention and treatment of inflammatory disorders, pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2014-12-11 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2014-12-16 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2014-12-20 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2014-12-30 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2014-12-30 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2014-12-31 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2015-01-06 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2015-01-06 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2015-01-23 | 9 RFNT P: |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2015-05-04 | 10 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2015-05-04 | 11 ARAA I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2015-05-11 | 12 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2015-05-11 | 13 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2015-05-11 | 14 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2015-05-15 | 15 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2015-06-06 | 16 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2015-06-06 | 17 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2015-06-24 | 18 NPUB O:Outgoing Correspondence |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2015-06-24 | 19 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2015-06-24 | 20 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2015-07-11 | 21 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2015-07-14 | 22 PUBO A:Allowance for Publication |
| REGISTERED-PRINCIPAL REGISTER | 2015-09-29 | 23 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2015-12-29 | 24 FICR P: |
| FINAL DISPOSITION PROCESSED | 2016-03-23 | 25 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2016-03-23 | 26 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2016-05-05 | 27 FINV P: |
| TEAS SECTION 71 & 15 RECEIVED | 2020-12-21 | 28 ES75 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2021-02-02 | 29 APRE A:Allowance for Publication |
| REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | 2021-02-08 | 30 C75A O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | 2021-02-08 | 31 NA75 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 